CC2018: Clostridium Difficile Colitis: What Is New? (T)

This session has been identified and designated as Credit to Meet ACS Accreditation/Verification Requirements for Trauma.

Session Description

This Panel Session will address the diagnosis of Clostridium difficile (C. difficile) colitis and various treatment options for C. difficile colitis including the use of vancomycin/flagyl, vancomycin enemas, diverting ileostomy, subtotal colectomy with end ileostomy, and fecal transplant. Treatment plans for recurrent and recalcitrant C. difficile colitis will also be addressed. Fecal transplant is a very promising treatment option for C. difficile colitis, with excellent reported results; however, the use of fecal transplant is very infrequent. This panel will identify when a fecal transplant should be considered as the treatment of choice, methods of fecal transplant, and recommendations for the development of a fecal transplant program.

Course Outline

  • Welcome
    Clarence E. Clark, MD, FACS, Atlanta, GA
  • Clostridium Difficile Colitis: Risk Factors, Diagnosis, and Prevention
    Konstantin Umanskiy, MD, FACS, Chicago, IL
  • Acute Clostridium Difficile Colitis: Is Colectomy Ever Indicated?
    Sook C. Hoang, MD, Charlottesville, VA
  • The Scoop on Poop: Fecal Transplantation in the Treatment of Clostridium Difficile Colitis
    Jessica R. Allegretti, MD, Boston, MA
  • Discussion
    Amy Halverson, MD, FACS, FASCRS,Chicago, IL

Target Audience

  • Practicing surgeons
  • Residents

Learning Objectives

  • Apply new knowledge and ideas to improve their surgical practice
  • Adapt concepts and quality measures in support of research advancements
  • Enhance the quality of patient care

Contact

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Self Assessment Credit
  • 1.50 Certificate of Completion
Course opens: 
10/05/2018
Course expires: 
12/31/2019


Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website: http://www.accme.org/requirements/accreditation-requirements-cme-providers/policies-and-definitions/financial-relationships-and-conflicts-interest

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation. 
 

(Download the full list of disclosures.)

Faculty and Disclosures

Clarence E. Clark, MD, FACS, Atlanta, GA - No Disclosures
Konstantin Umanskiy, MD, FACS, Chicago, IL -Applied Medical: Compensation: Speaker
Sook C. Hoang, MD, Charlottesville, VA - No Disclosures
Jessica R. Allegretti, MD, Boston, MA  -Finch therapeutics : Consulting Fee: Research support/ consulting 

Program Committee and Disclosures

CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - No Disclosures
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - No Disclosures

Members

David C. Borgstrom, MD, FACS, Morgantown, WV - No Disclosures
Daniel L. Dent, MD, FACS, San Antonio, TX - No Disclosures
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Audra A. Duncan, MD, FACS, London, ON - No Disclosures
Mariam F. Eskander, MD, Boston, MA - No Disclosures
Paula Ferrada, MD, FACS, Richmond, VA - No Disclosures
Neil H. Hyman, MD, FACS, Chicago, IL - No Disclosures
Martin S. Karpeh, Jr., MD, FACS, New York, NY - No Disclosures
Dennis H. Kraus, MD, FACS, New York, NY - No Disclosures
Kenneth W. Sharp, MD, FACS, Nashville, TN - No Disclosures
David A. Spain, MD, FACS, Stanford, CA - No Disclosures

Ex-Officios

Mary T. Hawn, MD, FACS, Stanford, CA - No Disclosures
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - No Disclosures

Consultants

Barbara Lee Bass, MD, FACS, FRCS(Hon), Houston, TX - No Disclosures
Quan-Yang Duh, MD, FACS, San Francisco, CA - No Disclosures
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - No Disclosures
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - No Disclosures
Valerie W. Rusch, MD, FACS, New York, NY - No Disclosures

 

Continuing Medical Education Credit Information

Accreditation

The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™

The American College of Surgeons designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Of the AMA PRA Category 1 Credits™ listed above, a maximum of 1.5 credits meets the requirements for Self-Assessment.

American College of Surgeons and ACGME Logos

Note: Residents will receive a Certificate of Completion.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Self Assessment Credit
  • 1.50 Certificate of Completion

Accreditation Period

Course opens: 
10/05/2018
Course expires: 
12/31/2019
Please login or register to take this course.